Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Accumulated Expenses (2020 - 2021)

Ensysce Biosciences (ENSC) has disclosed Accumulated Expenses for 2 consecutive years, with $411941.0 as the latest value for Q2 2021.

  • On a quarterly basis, Accumulated Expenses changed N/A to $411941.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $411941.0, a N/A change, with the full-year FY2020 number at $344792.0, changed N/A from a year prior.
  • Accumulated Expenses was $411941.0 for Q2 2021 at Ensysce Biosciences, up from $344792.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $411941.0 in Q2 2021 to a low of $344792.0 in Q4 2020.